Literature DB >> 22614387

Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.

Da Ma1, Gaya Hettiarachchi, Duc Nguyen, Ben Zhang, James B Wittenberg, Peter Y Zavalij, Volker Briken, Lyle Isaacs.   

Abstract

The solubility characteristics of 40-70% of new drug candidates are so poor that they cannot be formulated on their own, so new methods for increasing drug solubility are highly prized. Here, we describe a new class of general-purpose solubilizing agents-acyclic cucurbituril-type containers-which increase the solubility of ten insoluble drugs by a factor of between 23 and 2,750 by forming container-drug complexes. The containers exhibit low in vitro toxicity in human liver, kidney and monocyte cell lines, and outbred Swiss Webster mice tolerate high doses of the container without sickness or weight loss. Paclitaxel solubilized by the acyclic cucurbituril-type containers kills cervical and ovarian cancer cells more efficiently than paclitaxel alone. The acyclic cucurbituril-type containers preferentially bind cationic and aromatic drugs, but also solubilize neutral drugs such as paclitaxel, and represent an attractive extension of cyclodextrin-based technology for drug solubilization and delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22614387     DOI: 10.1038/nchem.1326

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  39 in total

1.  Complexation Thermodynamics of Cyclodextrins.

Authors:  Mikhail V. Rekharsky; Yoshihisa Inoue
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Selective molecular recognition, C-H bond activation, and catalysis in nanoscale reaction vessels.

Authors:  Dorothea Fiedler; Dennis H Leung; Robert G Bergman; Kenneth N Raymond
Journal:  Acc Chem Res       Date:  2005-04       Impact factor: 22.384

Review 3.  Prodrug strategies to overcome poor water solubility.

Authors:  Valentino J Stella; Kwame W Nti-Addae
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 4.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

Review 5.  Oral lipid-based formulations.

Authors:  David J Hauss
Journal:  Adv Drug Deliv Rev       Date:  2007-05-26       Impact factor: 15.470

6.  Cucurbit[n]urils: from mechanism to structure and function.

Authors:  Lyle Isaacs
Journal:  Chem Commun (Camb)       Date:  2008-11-27       Impact factor: 6.222

7.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

Authors:  Anil K Patri; Jolanta F Kukowska-Latallo; James R Baker
Journal:  Adv Drug Deliv Rev       Date:  2005-11-14       Impact factor: 15.470

Review 8.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.

Authors:  Christopher J H Porter; Natalie L Trevaskis; William N Charman
Journal:  Nat Rev Drug Discov       Date:  2007-03       Impact factor: 84.694

9.  Solubilisation and cytotoxicity of albendazole encapsulated in cucurbit[n]uril.

Authors:  Yunjie Zhao; Damian P Buck; David L Morris; Mohammad H Pourgholami; Anthony I Day; J Grant Collins
Journal:  Org Biomol Chem       Date:  2008-11-06       Impact factor: 3.876

Review 10.  Salt formation to improve drug solubility.

Authors:  Abu T M Serajuddin
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

View more
  65 in total

1.  Sustained Small Molecule Delivery from Injectable Hyaluronic Acid Hydrogels through Host-Guest Mediated Retention.

Authors:  Joshua E Mealy; Christopher B Rodell; Jason A Burdick
Journal:  J Mater Chem B       Date:  2015-09-18       Impact factor: 6.331

2.  Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.

Authors:  Gaya Hettiarachchi; Soumen K Samanta; Shane Falcinelli; Ben Zhang; Damien Moncelet; Lyle Isaacs; Volker Briken
Journal:  Mol Pharm       Date:  2016-01-22       Impact factor: 4.939

3.  Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs.

Authors:  Elizabeth L Robinson; Peter Y Zavalij; Lyle Isaacs
Journal:  Supramol Chem       Date:  2015-05-01       Impact factor: 1.688

4.  Fluorometric determination of morphine via its effect on the quenching of fluorescein by gold nanoparticles through a surface energy transfer process.

Authors:  John Nebu; J S Anjali Devi; R S Aparna; B Aswathy; A O Aswathy; George Sony
Journal:  Mikrochim Acta       Date:  2018-11-06       Impact factor: 5.833

5.  Glycoluril-Derived Molecular Clips are Potent and Selective Receptors for Cationic Dyes in Water.

Authors:  Nengfang She; Damien Moncelet; Laura Gilberg; Xiaoyong Lu; Vladimir Sindelar; Volker Briken; Lyle Isaacs
Journal:  Chemistry       Date:  2016-08-05       Impact factor: 5.236

6.  Monohydroxycucurbit[7]uril-coated stir-bar sorptive extraction coupled with high-performance liquid chromatography for the determination of apolar and polar organic compounds.

Authors:  Nan Dong; Lingxue Zhang; Jianmei Yao; Peijian Ma; Jing He; Tao Li; Yuan Wang
Journal:  Mikrochim Acta       Date:  2019-11-27       Impact factor: 5.833

7.  Cucurbit[7]uril Enables Multi-Stimuli-Responsive Release from the Self-Assembled Hydrophobic Phase of a Metal Organic Polyhedron.

Authors:  Soumen K Samanta; Jeffrey Quigley; Brittany Vinciguerra; Volker Briken; Lyle Isaacs
Journal:  J Am Chem Soc       Date:  2017-06-23       Impact factor: 15.419

8.  Cationic acyclic cucurbit[n]uril-type containers: synthesis and molecular recognition toward nucleotides.

Authors:  David Sigwalt; Peter Y Zavalij; Lyle Isaacs
Journal:  Supramol Chem       Date:  2016-04-13       Impact factor: 1.688

9.  Calabadion 1 selectively reverses respiratory and central nervous system effects of fentanyl in a rat model.

Authors:  Tharusan Thevathasan; Stephanie D Grabitz; Peter Santer; Paul Rostin; Oluwaseun Akeju; James D Boghosian; Monica Gill; Lyle Isaacs; Joseph F Cotten; Matthias Eikermann
Journal:  Br J Anaesth       Date:  2020-03-30       Impact factor: 9.166

10.  A Novel Strategy to Reverse General Anesthesia by Scavenging with the Acyclic Cucurbit[n]uril-type Molecular Container Calabadion 2.

Authors:  Daniel Diaz-Gil; Friederike Haerter; Shane Falcinelli; Shweta Ganapati; Gaya K Hettiarachchi; Jeroen C P Simons; Ben Zhang; Stephanie D Grabitz; Ingrid Moreno Duarte; Joseph F Cotten; Katharina Eikermann-Haerter; Hao Deng; Nancy L Chamberlin; Lyle Isaacs; Volker Briken; Matthias Eikermann
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.